Ritalin LA Prolonged Release Capsules 40mg
- Name:
Ritalin LA Prolonged Release Capsules 40mg
- Company:
Novartis Ireland Limited
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may not be renewed (A)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 22/01/19
(Click to Download)Click on this link to Download PDF directly
Novartis Ireland Limited
Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 22 January 2019 PIL
Reasons for updating
- Change to section 6 - marketing authorisation holder
Updated on 24 July 2018 SmPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 29 May 2018 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
Updated on 10 May 2018 SmPC
Reasons for updating
- New SmPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 15 March 2018 SmPC
Reasons for updating
- New SmPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 15 March 2018 SmPC
Reasons for updating
- Change to section 4.9 - Overdose
- Change to section 6.4 - Special precautions for storage
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 21 July 2017 PIL
Reasons for updating
- New PIL for new product
Updated on 21 July 2017 PIL
Reasons for updating
- Change to section 4 - possible side effects
Updated on 11 May 2017 SmPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 29 June 2015 SmPC
Reasons for updating
- Change to Section 4.8 – Undesirable effects - how to report a side effect
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Updated on 30 April 2015 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Addition of information on reporting a side effect.
Updated on 29 April 2015 PIL
Reasons for updating
- Change to, or new use for medicine
Updated on 10 April 2015 SmPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
-
Section 4.8 (Undesirable effects): The adverse reaction(s) of logorrhea should be added under the SOC psychiatric disorders with a frequency unknown
Updated on 27 June 2013 PIL
Reasons for updating
- Improved electronic presentation
Updated on 5 September 2012 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change to improve clarity and readability
Updated on 29 August 2012 SmPC
Reasons for updating
- New individual SPC (was previously included in combined SPC)
- Individual presentations superseded by joint SPC
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Updated on 1 August 2012 PIL
Reasons for updating
- Improved electronic presentation
Updated on 29 July 2011 PIL
Reasons for updating
- Change to date of revision
- PIL retired pending re-submission
Updated on 27 June 2006 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change to side-effects
- Change to date of revision
Updated on 27 August 2004 PIL
Reasons for updating
- New PIL for medicines.ie